Dr. Matulonis is the Program Leader and Medical Director for the Gynecologic Oncology Program and the Interim Director of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. Her research is focused on targeted therapies for gynecologic malignancies, with a specific interest in the development of new therapeutics in ovarian cancer and rationally targeted drug and drug combination selection. She is also a principal investigator of several clinical trials and translational studies for ovarian cancer and other gynecologic cancers.